These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38944426)

  • 1. Photoimmunotherapy of HER2-expressing Breast Cancer Cells.
    Klemenz L; Wolf I; Storz J; Schultze-Seemann S; Gratzke C; Lauw S; Brückner R; Wolf P
    Cancer Genomics Proteomics; 2024; 21(4):361-367. PubMed ID: 38944426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dye Conjugates Targeting EGFR and HER2 for the Photoimmunotherapy of Bladder Cancer.
    Huber F; Wolf I; Storz J; Schultze-Seemann S; Lauw S; Klemenz L; Miernik A; Gratzke C; Brückner R; Wolf P
    Anticancer Res; 2024 May; 44(5):1837-1844. PubMed ID: 38677753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoimmunotherapy of Prostate Cancer With Antibody and Fab Fragments Targeting the Prostate Specific Membrane Antigen.
    Waibel S; Graf N; Storz J; Schultze-Seemann S; Lauw S; Gratzke C; Brückner R; Wolf P; Wolf I
    Anticancer Res; 2024 Jun; 44(6):2343-2348. PubMed ID: 38821609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Near-Infrared Photoimmunotherapy Using Trastuzumab and Small Protein Mimetic for HER2-Positive Breast Cancer.
    Yamaguchi H; On J; Morita T; Suzuki T; Okada Y; Ono J; Evdokiou A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trastuzumab-based near-infrared photoimmunotherapy in xenograft mouse of breast cancer.
    Yamashita S; Kojima M; Onda N; Yoshida T; Shibutani M
    Cancer Med; 2023 Feb; 12(4):4579-4589. PubMed ID: 36259134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).
    Siddiqui MR; Railkar R; Sanford T; Crooks DR; Eckhaus MA; Haines D; Choyke PL; Kobayashi H; Agarwal PK
    Sci Rep; 2019 Feb; 9(1):2084. PubMed ID: 30765854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms.
    Ito K; Mitsunaga M; Arihiro S; Saruta M; Matsuoka M; Kobayashi H; Tajiri H
    BMC Cancer; 2016 Jan; 16():37. PubMed ID: 26810644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-Infrared Photoimmunotherapy Using a Small Protein Mimetic for HER2-Overexpressing Breast Cancer.
    Yamaguchi H; Pantarat N; Suzuki T; Evdokiou A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31757056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging.
    Ito K; Mitsunaga M; Nishimura T; Kobayashi H; Tajiri H
    Oncotarget; 2016 Mar; 7(12):14143-52. PubMed ID: 26909859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near infrared photoimmunotherapy prevents lung cancer metastases in a murine model.
    Sato K; Nagaya T; Nakamura Y; Harada T; Choyke PL; Kobayashi H
    Oncotarget; 2015 Aug; 6(23):19747-58. PubMed ID: 25992770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near infrared photoimmunotherapy for lung metastases.
    Sato K; Nagaya T; Mitsunaga M; Choyke PL; Kobayashi H
    Cancer Lett; 2015 Aug; 365(1):112-21. PubMed ID: 26021765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer neovasculature-targeted near-infrared photoimmunotherapy (NIR-PIT) for gastric cancer: different mechanisms of phototoxicity compared to cell membrane-targeted NIR-PIT.
    Nishimura T; Mitsunaga M; Ito K; Kobayashi H; Saruta M
    Gastric Cancer; 2020 Jan; 23(1):82-94. PubMed ID: 31302791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer.
    Ito K; Mitsunaga M; Nishimura T; Saruta M; Iwamoto T; Kobayashi H; Tajiri H
    Bioconjug Chem; 2017 May; 28(5):1458-1469. PubMed ID: 28402624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cells.
    Shimoyama K; Kagawa S; Ishida M; Watanabe S; Noma K; Takehara K; Tazawa H; Hashimoto Y; Tanabe S; Matsuoka J; Kobayashi H; Fujiwara T
    Breast Cancer Res Treat; 2015 Feb; 149(3):597-605. PubMed ID: 25616354
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Cai Z; Chattopadhyay N; Yang K; Kwon YL; Yook S; Pignol JP; Reilly RM
    Nucl Med Biol; 2016 Dec; 43(12):818-826. PubMed ID: 27788375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy.
    Zhang B; Shi J; Shi X; Xu X; Gao L; Li S; Liu M; Gao M; Jin S; Zhou J; Fan D; Wang F; Ji Z; Bian Z; Song Y; Tian W; Zheng Y; Xu L; Li W
    Drug Resist Updat; 2024 May; 74():101068. PubMed ID: 38402670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
    Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
    World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local Radiation Treatment of HER2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled with
    Cai Z; Yook S; Lu Y; Bergstrom D; Winnik MA; Pignol JP; Reilly RM
    Pharm Res; 2017 Mar; 34(3):579-590. PubMed ID: 27987070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-infrared photoimmunotherapy (NIR-PIT) on cholangiocarcinoma using a novel catheter device with light emitting diodes.
    Hirata H; Kuwatani M; Nakajima K; Kodama Y; Yoshikawa Y; Ogawa M; Sakamoto N
    Cancer Sci; 2021 Feb; 112(2):828-838. PubMed ID: 33345417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer.
    von Arx C; De Placido P; Caltavituro A; Di Rienzo R; Buonaiuto R; De Laurentiis M; Arpino G; Puglisi F; Giuliano M; Del Mastro L
    Cancer Treat Rev; 2023 Feb; 113():102500. PubMed ID: 36587473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.